FindTrial
Sign In

Cancelled by the investigator Study for the false positive rate of IgM / IgG antibody test kit for novel coronavirus pneumonia (COVID-19) in different inpatients

Study for the false positive rate of IgM / IgG antibody test kit for novel coronavirus pneumonia (COVID-19) in different inpatients

Status
Unknown
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030085
Enrollment
Unknown
Registered
2020-02-22
Start date
2020-02-22
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

COVID-19
Gold Standard:Nucleic acid detection method of COVID-19
Index test:IgM/IgG&#32
detection&#32
method&#32
of&#32

Sponsors

Department of Burns and Plastic Surgery, Affiliated Hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Common inpatient, volunteer and fever patient; 2. Patients who are older than 12 years, gender unlimited; 3. Consenting or the guardian of a minor is willing to participate in this trial and will sign the informed consent.

Exclusion criteria

Exclusion criteria: With acute cardio-cerebrovascular liver and kidney function damage, or combined with other important organ injury;

Design outcomes

Primary

MeasureTime frame
Positive/Negtive;False positive of rate ;—

Countries

China

Contacts

Public ContactZairong Wei

Affiliated Hospital of Zunyi Medical University

188116999@qq.com+86 15208660008

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026